Ausgabe 6/2022
Inhalt (5 Artikel)
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer
Giulio Francolini, Vanessa Di Cataldo, Beatrice Detti, Gabriele Simontacchi, Mauro Loi, Marianna Valzano, Isacco Desideri, Icro Meattini, Monica Mangoni, Lorenzo Livi
Stereotactic radiotherapy of nodal oligometastases from prostate cancer: a prisma-compliant systematic review
Alice Zamagni, Mattia Bonetti, Milly Buwenge, Gabriella Macchia, Francesco Deodato, Savino Cilla, Erika Galietta, Lidia Strigari, Francesco Cellini, Luca Tagliaferri, Silvia Cammelli, Alessio Giuseppe Morganti
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer
Sophia M. Orbach, Michael D. Brooks, Yining Zhang, Scott E. Campit, Grace G. Bushnell, Joseph T. Decker, Ryan J. Rebernick, Sriram Chandrasekaran, Max S. Wicha, Jacqueline S. Jeruss, Lonnie D. Shea
Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma
Taneli T. Mattila, Madhura Patankar, Juha P. Väyrynen, Kai Klintrup, Jyrki Mäkelä, Anne Tuomisto, Pentti Nieminen, Markus J. Mäkinen, Tuomo J. Karttunen
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4
Raoud Marayati, Janet Julson, Laura V. Bownes, Colin H. Quinn, Laura L. Stafman, Andee M. Beierle, Hooper R. Markert, Sara C. Hutchins, Jerry E. Stewart, David K. Crossman, Anita B. Hjelmeland, Elizabeth Mroczek-Musulman, Elizabeth A. Beierle